BridgeMD
New treatment option for Chronic Dizziness
Official title A Study Of Auricular Transcutaneous Vagus Nerve Stimulation In Chronic Dizziness
ClinicalTrials.gov ID: NCT07420803
What this study is testing
- What it's testing
- The purpose of this study is to measure the change in dizziness, as measured by change in Dizziness Handicap Inventory (DHI) score, following a 4-week treatment period with auricular transcutaneous vagus nerve stimulation (aTVNS).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18-75, Persistent Postural-Perceptual Dizziness (PPPD) diagnosis per International Classification of Vestibular Disorders (ICVD).
- Persistent dizziness ≥3 months and at least 1 dizziness exacerbation/day during 2-week run-in.
- On stable medications/therapy for ≥4 weeks prior to baseline (if any).
You likely can't join if
- Uncompensated peripheral/central vestibular deficit, sensory-afferent or cerebellar ataxia.
- Cardiac disease (coronary disease, unstable arrhythmia), recurrent syncope (\>1 in past 12 months).
- Neck surgery, vagotomy, or any condition interfering with vagal stimulation.
- Pregnancy.
The study team makes the final eligibility decision.
Where it's taking place
- Jacksonville, Florida, United States
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jacksonville, Florida, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.